RAP 3.57% 14.5¢ resapp health limited

Ann: ResApp Provides SMARTCOUGH-C-2 Study Update, page-4

  1. 1,182 Posts.
    lightbulb Created with Sketch. 24
    Great news and yes clean cough sounds known to research teams.

    Better than expected enrollment numbers.

    Resapp main market is Telehealth online visits with Dr's .

    "Ping!!!!"

    Hospital uptake will be bonus income.

    I see commercialization of Resapp with CE mark will happen before FDA approval.

    Well done RAP team.

    Thank you.
    MB
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.